Literature DB >> 17489985

Gene-gene and gene-environment interactions between alcohol drinking habit and polymorphisms in alcohol-metabolizing enzyme genes and the risk of head and neck cancer in Japan.

Akio Hiraki1, Keitaro Matsuo, Kenji Wakai, Takeshi Suzuki, Yasuhisa Hasegawa, Kazuo Tajima.   

Abstract

Alcohol consumption is a strong risk factor for squamous cell carcinoma of the head and neck (SCCHN). The genetic polymorphisms aldehyde dehydrogenase2 (ALDH2) Glu487Lys and alcohol dehydrogenase 2 (ADH2) His47Arg, which have a strong impact on alcohol metabolism, are common in the Japanese population. To clarify the significance of these polymorphisms in SCCHN carcinogenesis, we conducted a matched case-control study with 239 incident SCCHN subjects and 716 non-cancer controls. Both ADH2 Arg/Arg and ALDH2 Glu/Lys were found to be independently associated with increased risk, with odds ratios (OR) of 2.67 (95% confidence interval [CI] 1.51-4.57) and 1.66 (95% CI 1.20-2.31), respectively. Further, compared with subjects having both ADH2 His/His and ALDH2 Glu/Glu, the adjusted OR and its 95% CI for those with both ADH2 Arg/Arg and ALDH2 Glu/Lys was 5.00 (2.32-10.71) in all subjects. This combination effect was evident in heavy drinkers (OR 11.3, 95% CI 2.97-43.3) but not in moderate or non-drinkers. Statistically significant gene-environment interactions between the two polymorphisms and drinking level were seen (ADH2 P = 0.035, ALDH2, P = 0.013). Furthermore, we also found a statistically significant gene-gene interaction between the two polymorphisms (P = 0.042). In conclusion, this case-control study showed a significantly increased risk of SCCHN in subjects with the ADH2 Arg/Arg and ALDH2 Glu/Lys polymorphisms in a Japanese population. In addition, our results also demonstrated that this risk was associated with significant gene-gene interactions between ADH2 and ALDH2 polymorphisms, as well as gene-environment interactions between these polymorphisms and alcohol drinking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17489985     DOI: 10.1111/j.1349-7006.2007.00505.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  21 in total

1.  Association between ADH1B and ADH1C polymorphisms and the risk of head and neck squamous cell carcinoma.

Authors:  Yong Bae Ji; Seung Hwan Lee; Kyung Rae Kim; Chul Won Park; Chang Myeon Song; Byung Lae Park; Hyoung Doo Shin; Kyung Tae
Journal:  Tumour Biol       Date:  2015-01-21

2.  A single nucleotide polymorphism in the alcohol dehydrogenase 7 gene (alanine to glycine substitution at amino acid 92) is associated with the risk of squamous cell carcinoma of the head and neck.

Authors:  Sheng Wei; Zhensheng Liu; Hui Zhao; Jiangong Niu; Li-E Wang; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

3.  A variant allele of ADH1B and ALDH2, is associated with the risk of esophageal cancer.

Authors:  Haiyong Gu; Dingxu Gong; Guowen Ding; Wenbo Zhang; Chao Liu; Pengcheng Jiang; Suocheng Chen; Yijang Chen
Journal:  Exp Ther Med       Date:  2012-04-17       Impact factor: 2.447

4.  Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer.

Authors:  Anne M Hakenewerth; Robert C Millikan; Ivan Rusyn; Amy H Herring; Kari E North; Jill S Barnholtz-Sloan; William F Funkhouser; Mark C Weissler; Andrew F Olshan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-22       Impact factor: 4.254

5.  Alcohol dehydrogenase-1B Arg47His polymorphism is associated with head and neck cancer risk in Asian: a meta-analysis.

Authors:  Yu Zhang; Ning Gu; Limin Miao; Hua Yuan; Ruixia Wang; Hongbing Jiang
Journal:  Tumour Biol       Date:  2014-10-17

6.  Association between gastric cardia adenocarcinoma risk and alcohol flushing response, but not alcohol consumption.

Authors:  Qingxu Song; Peng Hu; Jianbo Wang; Yibin Jia; Guangyu Zhang; Li Lv; Yuan Liu; Yufeng Cheng
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

7.  Sequence Variants and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium.

Authors:  Shu-Chun Chuang; Antonio Agudo; Wolfgang Ahrens; Devasena Anantharaman; Simone Benhamou; Stefania Boccia; Chu Chen; David I Conway; Eleonora Fabianova; Richard B Hayes; Claire M Healy; Ivana Holcatova; Kristina Kjaerheim; Pagona Lagiou; Philip Lazarus; Tatiana V Macfarlane; Manoj B Mahimkar; Dana Mates; Keitaro Matsuo; Franco Merletti; Andres Metspalu; Hal Morgenstern; Joshua Muscat; Gabriella Cadoni; Andrew F Olshan; Mark Purdue; Heribert Ramroth; Peter Rudnai; Stephen M Schwartz; Lorenzo Simonato; Elaine M Smith; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Renato Talamini; Peter Thomson; Qingyi Wei; David Zaridze; Zuo-Feng Zhang; Ariana Znaor; Paul Brennan; Paolo Boffetta; Mia Hashibe
Journal:  Front Oncol       Date:  2011-07-12       Impact factor: 6.244

Review 8.  Oral squamous cell cancer: early detection and the role of alcohol and smoking.

Authors:  Anna G Zygogianni; George Kyrgias; Petros Karakitsos; Amanta Psyrri; John Kouvaris; Nikolaos Kelekis; Vassilis Kouloulias
Journal:  Head Neck Oncol       Date:  2011-01-06

Review 9.  Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency.

Authors:  Rachel A Montel; Carlos Munoz-Zuluaga; Katie M Stiles; Ronald G Crystal
Journal:  Cancer Gene Ther       Date:  2021-11-19       Impact factor: 5.854

Review 10.  The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.

Authors:  Hong Zhang; Liwu Fu
Journal:  Acta Pharm Sin B       Date:  2021-02-11       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.